Latest Breaking News On - Olivia manser - Page 4 : comparemela.com

Autolus Therapeutics announces publication in Nature Communications

LONDON, Feb. 22, 2024 Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces a publication in Nature.

City ofUnited kingdomLauren williamsJulia wilsonSusana noonanOlivia manserNature communicationsExchange commission onExchange commissionSa noonan communicationsStructure guided engineeringAutolus therapeuticsPrivate securities litigation reform actAutolu annual reportAutolu quarterly report

BioNTech SE: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

BioNTech SE: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesUgur sahinJulia wilsonSusana noonanFosun pharmaOlivia manserStefan klotterSa noonan communicationsExchange commissionRoche groupExchange commission onChristian itinAutolu american depositary sharesDuality biologics

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

Strategic alliance leverages manufacturing and commercial infrastructure as well as technology with the aim to advance both companies’ autologous CAR-T programs towards market, pending market.

United kingdomUnited statesCity ofSusana noonanJulia wilsonUgur sahinFosun pharmaOlivia manserRoche groupExchange commission onExchange commissionSa noonan communicationsAutolus therapeuticsChristian itinChief executive officerAutolu american depositary shares

Autolus Announces Pricing of Underwritten Offering

LONDON, Feb. 08, 2024 Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of an underwritten.

City ofUnited kingdomUnited statesNew yorkSusana noonanOlivia manserJulia wilsonNeedham companyEquity syndicate prospectus departmentTruist securities incVan lanschot kempen united states incSa noonan communicationsExchange commissionProspectus departmentMizuho securities united statesDepositary shares

Autolus Therapeutics announces publication in ACS Chemical Biology

LONDON, Jan. 23, 2024 Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a publication in ACS Chemical.

City ofUnited kingdomOlivia manserJulia wilsonSusana noonanLauren williamsExchange commission onExchange commissionSa noonan communicationsChief scientific officerSmall molecule control system basedMinocycline induced disruptionRapamycin activated caspaseBased suicideAutolus therapeuticsPrivate securities litigation reform act